Viewing Study NCT02162667


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-06-30 @ 10:19 PM
Study NCT ID: NCT02162667
Status: COMPLETED
Last Update Posted: 2022-08-03
First Post: 2014-06-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer
Sponsor: Celltrion
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Carcinoma of Breast View
Keywords: